The presence or absence of CTCs, CA19-9 ≥37 U/mL or CEA ≥5 ng/mL all failed to stratify PFS of PC patients (Supplementary Fig. 3 and Supplementary Fig. 4). This evidence concerns the gene CEACAM5 and pachyonychia congenita.